Inhibition of inward rectifier K+ currents by angiotensin II in rat atrial myocytes: Lack of effects in cells from spontaneously hypertensive rats

Hypertension Research

Volumn 29, Issue 11, 2006, Pages 923-934

  Sonoyama, Kazuhiko ^a   Ninomiya, Haruaki ^a   Igawa, Osamu ^a   Kaetsu, Yasuhiro ^a   Furuse, Yoshiyuki ^a   Hamada, Toshihiro ^a   Miake, Junichiro ^a   Li, Peili ^a   Yamamoto, Yasutaka ^b   Ogino, Kazuhide ^a   Yoshida, Akio ^a   Taniguchi, Shin Ichi ^a   Kurata, Yasutaka ^c   Matsuoka, Satoshi ^d   Narahashi, Toshio ^e   Shiota, Goshi ^a   Nozawa, Yoshihisa ^f   Matsubara, Hiroaki ^g   Horiuchi, Masatsugu ^h   Shirayoshi, Yasuaki ^b   Hisatome, Ichiro ^b   more..

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NORTHWESTERN UNIVERSITY   (United States)

^f TAIHO PHARMACEUTICAL CO LTD   (Japan)

^g KANSAI MEDICAL UNIVERSITY   (Japan)

^h EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II type 1; Angiotension II; Gi ; Hypertension; Inward rectifier K+ currents

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; OLMESARTAN; PERTUSSIS TOXIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; CELL STRAIN COS7; CONTROLLED STUDY; HEART ATRIUM MUSCLE; IC 50; IMMUNOPRECIPITATION; INHIBITION KINETICS; ISOTOPE LABELING; METABOLIC INHIBITION; MUSCLE CELL; NONHUMAN; POTASSIUM CURRENT; PROTEIN BINDING; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; GENE EXPRESSION; HEART ATRIA; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION;

EID: 33846063325     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.923     Document Type: Article

References (49)

1. Hille B: Ionic Channels in Excitable Membrane: Endplate Channels and Other Electrically Unexcitable Channels, 2nd ed. Massachusetts, Sinauer Associates Inc, 1992, pp 127-130.
2. Almond F, Alvarez JL, Gauzier HM, et al: Ionic basis of ventricular arrhythmias in remodeled rat heart during long-term myocardial infarction. Cardiovasc Res 1999; 42: 402-415.
3. + channel in human cardiac myocytes: alteration in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation 1995; 92: 164-174.
4. Xia M, Jin Q, Bendahhou S, et al: A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commmun 2005; 332: 1012-1019.
5. Caballero R, Gomez R, Moreno I, et al: Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current. Cardiovasc Res 2001; 62: 86-95.
6. + channels in porcine cerebral capillary endothelial cells. J Membr Biol 1991; 123: 55-62.
7. Kurtz A, Penner R: Angiotensin II induces oscillation of intracellular calcium and blocks anomalous inward rectifying potassium current in mouse renal juxtaglomerular cells. Proc Natl Acad U S A 1989; 86: 3423-3427.
8. Morita H, Kimura J, Endoh M: Angiotensin II activation of a chloride current in rabbit cardiac myocytes. J Physiol 1995; 483: 119-130.
9. + channels are regulated independently by protein kinases and ATP hydrolysis. Neuron 1994; 13: 1413-1420.
10. + channel Kir2.1b is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system. Circulation 2002; 106: 1493-1499.
11. + current in guinea-pig ventricular myocytes. J Physiol 1995; 486: 647-659.
12. Baker KM, Singer HA: Identification and characterization of guinea pig angiotensin II ventricular and atrial receptors: coupling to inositol phosphate production. Circ Res 1988; 62: 896-904.
13. Chen SA, Chang MS, Chiang BN, et al: Electromechanical effects of angiotensin in human atrial tissues. J Mol Cell Cardiol 1991; 23: 483-493.
14. Bonnardeaux JL, Regoli D: Action of angiotensin and analogues on the heart. Can J Physiol Pharm 1974; 52: 50-60.
15. Li X, Jiang W: Electrical remodeling of membrane ionic channels of hypertrophied ventricular myocytes from spontaneously hypertensive rats. Chin Med J (Engl) 2000; 113: 584-587.
16. f in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation 1996; 94: 1674-1681.
17. + channels by Class 1 antiarrhythmic agents in the ventricular myocytes and the guinea pig papillary muscle. Biochim Biophys Acta 1999; 1418: 320-334.
18. Tsutsumi Y, Matsubara H, Masaki H, et al: Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999; 104: 925-935.
19. Nozawa Y, Haruno A, Oda N, et al: Angiotensin II receptor subtypes in bovine and human ventricular myocardium. J Pharmacol Exp Ther 1994; 270: 566-571.
20. Sato R, Koumi S, Singer DH, et al: Amiodarone blocks the inward rectifier potassium channel in isolated guinea pig ventricular cells. J Pharmacol Exp Ther 1994; 269: 1213-1219.
21. Crumb WJ Jr, Munfakh N, Heck HA, et al: Fatty acid block of the transient outward current in adult human atrium. J Pharmacol Exp Ther 1999; 289: 386-391.
22. 2+ in left ventricular myocyte sub-types from rabbits with heart failure. Cardiovasc Res 2000; 45: 397-409.
23. 1 receptor. J Biol Chem 1997; 272: 23382-23388.
24. 1)-receptor-immunoreactive fibers in the hypothalamus of rats: angiotensin II-sensitive tanycytes in the ependyma of the third ventricle? Brain Res 2003; 967: 281-284.
25. Sarlos S, Rizkalla B, Moravski CJ, et al: Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 2003; 163: 879-887.
26. 1)-receptors, a light and electron microscopic study. Brain Res 2004; 1008: 224-235.
27. Kumar R, Arita T, Joyner RW: Adenosine and carbachol are not equivalent in their effects on L-type calcium current in rabbit ventricular cells. J Mol Cell Cardiol 1996; 28: 403-415.
28. 2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 1997; 11: 1266-1277.
29. 2 receptors of angiotensin II. Cell Signal 1996; 8: 525-532.
30. Balemba OB, Saffer MJ, Heppner TJ, et al: Spontaneous electrical rhythmicity and the role of the sarcoplasmic reticulum in the excitability of guinea pig gallbladder smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2006; 290: G655-G664.
31. Thibault C, Anand-Srivastava MB: Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Lett 1992; 313: 160-164.
32. 1b receptors: pharmacological and functional requirements. FEBS Lett 1994; 349: 365-370.
33. Okamoto Y, Ninomiya H, Miwa S, et al: Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells. J Biol Chem 2000; 275: 6439-6446.
34. Ishii I, Saito E, Izumi T, et al: Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor. Role of cytoplasmic tail phosphorylation in each process. J Biol Chem 1998; 273: 9878-9885.
35. A receptor abrogated the binding activity to ET-1. Biochem Biophys Res Commun 1992; 187: 1241-1248.
36. Zhang Y, Hong J, Fabucci ME, et al: Translational control of the rat angiotensin type 1a receptor by alternative splicing. Gene 2004; 341: 93-100.
37. Tanaka M, Umemoto S, Kawahara S, et al: Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28: 67-77.
38. Yagi S, Morita T, Katayama S: Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress. Hypertens Res 2004; 27: 129-135.
39. White BH, Sidhu A: Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling. J Hypertens 1998; 16: 1659-1665.
40. Kosunen KJ: A simple method for measurement of angiotensin II concentration in human plasma. Scand J Clin Lab Invest 1976; 36: 467-472.
41. Durvasula RV, Petermann AT, Hiromura K, et al: Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65: 30-39.
42. Agoudemos MM, Greene AS: Localization of the renin-angiotensin system components to the skeletal muscle microcirculation. Microcirculation 2005; 12: 627-636.
43. Wachtell K, Lehto M, Gerdts E, et al: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention for End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45: 712-719.
44. Goette A, Staack T, Rocken C: Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000; 35: 1669-1677.
45. Nakashima H, Kumagai K, Urata H, et al: Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101: 2612-2617.
46. Kannel WB, Wolf PA, Benjamin EJ, et al: Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
47. Dahlof B, Hornestam B, Aurup P: Losartan decreases the risk of stroke in hypertensive patients with atrial fibrillation and left ventricular hypertrophy. Eur Heart J 2002; 23: 412.
48. + currents in atrial myocytes isolated from WKY rats and SHRs. Circ J 2006; 70 (Suppl): 544.
49. Sonoyama K, Igawa O, Miake J, et al: Effects of angiotensin II on the action potential durations of atrial myocytes in hypertensive rats. Hypertens Res 2005; 28: 173-179.